Brief: SAMSUNG PHARMACEUTICAL. signs 4.4 bln won contract
July 1 (Reuters) - SAMSUNG PHARMACEUTICAL.CO.,Ltd.
001360.KS :
* Says it signs a contract with a Korea-based co, to supply
hangover resolve medicines
* Says contract price of 4.4 billion won
Source text in Korean: http://me2.do/5bFAEZqf
Further company coverage: 001360.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: lusha.zhang.reuters.com@reuters.net))
Recent news on Samsung Pharm
See all newsBrief: Samsung Pharmaceutical Wins 33.5 Billion Won Order
Brief: Samsung Pharmaceutical Says Acquires Shares Worth 12.5 bln Won In True Life Insurance Bank
Brief: Samsung Pharmaceutical To Invest 15.3 Billion Won To Build New Manufacturing Line
Brief: Samsung Pharmaceutical To Sell 8 Bln Won Asset To Samsung Medicos
Brief: Samsung Pharmaceutical Plans 20 Bln Won Investment In S.Korea